Clinical Trials Detalhe
Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]
General Information
Gender
ALL
Age
N/A
Phase
PHASE2
Study Type
INTERVENTIONAL
Location
Almada, Portugal
Amadora, Portugal
Carnaxide, Portugal
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT00785954Summary
The purpose of this study is to determine whether KAI-9803 is safe and effective in reducing infarct size in subjects with ST elevation myocardial infarction (heart attack) undergoing a percutaneous coronary intervention (PCI). A select number of sites will also participate in a substudy where eligible patients will undergo an additional procedure;cardiac magnetic resonance imaging.
Conditions
Myocardial Infarction
Cardiovascular Diseases
Pathologic Processes
Eligibility
Inclusion Criteria: * Acute STEMI and has a planned emergent primary PCI procedure * Continuous symptoms of cardiac ischemia and present to the primary PCI facility within 6 hours of symptom onset Exclusion Criteria: * Persistent systolic blood pressure \< 90 mm Hg